Antares Pharma Inc

NASDAQ:ATRS  
4.12
-0.07 (-1.67%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)685.49M
Current PE10.99
Forward PE 37.45
2yr Forward PE 16.48
See more stats
Estimates Current Quarter
Revenue$42.97 Million
Adjusted EPS$0.01
See more estimates
10-Day MA$4.21
50-Day MA$4.03
200-Day MA$3.74
See more pivots

Antares Pharma Inc Stock, NASDAQ:ATRS

100 Princeton South, Suite 300, Ewing, New Jersey 08628
United States of America
Phone: +1.609.359.3020
Number of Employees: 185

Description

Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.